Tomoya Yokota (T Yokota)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 38

Top Topics

Locally Advanced

Squamous Cell Carcinoma

Tyrosine Kinase

Top Venues

Nature medicine

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

International journal of clinical oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Jordi Rodon Ahnert, Silvia Damian, Muhammad Furqan, Jesús García-Donas, Hiroo Imai, Antoine Italiano, Iben Spanggaard, Makoto Ueno, Tomoya Yokota, Maria Luisa Veronese, Natalia Oliveira, Xin Li, Aidan Gilmartin, Michael Schaffer, Lipika Goyal
Pemigatinib in previously treated solid tumors with activating FGFR1-FGFR3 alterations: phase 2 FIGHT-207 basket trial. Nature medicine 30 (6) (2024)
Miho Kawashima, Takanori Kawabata, Chikako Ando, Megumi Sakuma, Takashi Aoyama, Hirofumi Ogawa, Tomoya Yokota, Yusuke Onozawa, Takashi Mukaigawa, Tetsuo Nishimura, Keita Mori, Takashi Yurikusa
Radiation-induced xerostomia and cariogenic dietary habits. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 32 (2) (2024)
Jordi Rodon Ahnert, Silvia Damian, Muhammad Furqan, Jesús García-Donas, Hiroo Imai, Antoine Italiano, Iben Spanggaard, Makoto Ueno, Tomoya Yokota, Maria Luisa Veronese, Natalia Oliveira, Xin Li, Aidan Gilmartin, Michael Schaffer, Lipika Goyal
Pemigatinib in previously treated solid tumors with activating FGFR1-FGFR3 alterations: phase 2 FIGHT-207 basket trial. Nature medicine 30 (6) (2024)
Satoshi Suzuki, Tomoya Yokota, Akifumi Notsu, Satoshi Hamauchi, Yusuke Onozawa, Kunihiro Fushiki, Kotoe Oshima, Takeshi Kawakami, Takahiro Tsushima, Hirofumi Yasui, Hirofumi Ogawa, Tsuyoshi Onoe, Keisuke Kawatani, Kentaro Yamazaki
Impact of relative cisplatin dose to skeletal muscle mass on adverse events in patients with head and neck cancer undergoing chemoradiotherapy. The oncologist (2024)
Jordi Rodon Ahnert, Silvia Damian, Muhammad Furqan, Jesús García-Donas, Hiroo Imai, Antoine Italiano, Iben Spanggaard, Makoto Ueno, Tomoya Yokota, Maria Luisa Veronese, Natalia Oliveira, Xin Li, Aidan Gilmartin, Michael Schaffer, Lipika Goyal
Publisher Correction: Pemigatinib in previously treated solid tumors with activating FGFR1-FGFR3 alterations: phase 2 FIGHT-207 basket trial. Nature medicine (2024)
Tomoya Yokota, Satoshi Hamauchi, Takeshi Kawakami, Kunihiro Fushiki
Lenvatinib rechallenge after failure of lenvatinib and sorafenib in metastatic thyroid cancer. Investigational new drugs 42 (4) (2024)
Jordi Rodon Ahnert, Silvia Damian, Muhammad Furqan, Jesús García-Donas, Hiroo Imai, Antoine Italiano, Iben Spanggaard, Makoto Ueno, Tomoya Yokota, Maria Luisa Veronese, Natalia Oliveira, Xin Li, Aidan Gilmartin, Michael Schaffer, Lipika Goyal
Pemigatinib in previously treated solid tumors with activating FGFR1-FGFR3 alterations: phase 2 FIGHT-207 basket trial. Nature medicine (2024)
Jordi Rodon Ahnert, Silvia Damian, Muhammad Furqan, Jesús García-Donas, Hiroo Imai, Antoine Italiano, Iben Spanggaard, Makoto Ueno, Tomoya Yokota, Maria Luisa Veronese, Natalia Oliveira, Xin Li, Aidan Gilmartin, Michael Schaffer, Lipika Goyal
Pemigatinib in previously treated solid tumors with activating FGFR1-FGFR3 alterations: phase 2 FIGHT-207 basket trial. Nature medicine 30 (6) (2024)
Miho Kawashima, Takanori Kawabata, Chikako Ando, Megumi Sakuma, Takashi Aoyama, Hirofumi Ogawa, Tomoya Yokota, Yusuke Onozawa, Takashi Mukaigawa, Tetsuo Nishimura, Keita Mori, Takashi Yurikusa
Radiation-induced xerostomia and cariogenic dietary habits. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 32 (2) (2024)
Jordi Rodon Ahnert, Silvia Damian, Muhammad Furqan, Jesús García-Donas, Hiroo Imai, Antoine Italiano, Iben Spanggaard, Makoto Ueno, Tomoya Yokota, Maria Luisa Veronese, Natalia Oliveira, Xin Li, Aidan Gilmartin, Michael Schaffer, Lipika Goyal
Pemigatinib in previously treated solid tumors with activating FGFR1-FGFR3 alterations: phase 2 FIGHT-207 basket trial. Nature medicine 30 (6) (2024)
Jordi Rodon Ahnert, Silvia Damian, Muhammad Furqan, Jesús García-Donas, Hiroo Imai, Antoine Italiano, Iben Spanggaard, Makoto Ueno, Tomoya Yokota, Maria Luisa Veronese, Natalia Oliveira, Xin Li, Aidan Gilmartin, Michael Schaffer, Lipika Goyal
Pemigatinib in previously treated solid tumors with activating FGFR1-FGFR3 alterations: phase 2 FIGHT-207 basket trial. Nature medicine (2024)
Tomoya Yokota, Satoshi Hamauchi, Takeshi Kawakami, Kunihiro Fushiki
Lenvatinib rechallenge after failure of lenvatinib and sorafenib in metastatic thyroid cancer. Investigational new drugs (2024)
Jordi Rodon Ahnert, Silvia Damian, Muhammad Furqan, Jesús García-Donas, Hiroo Imai, Antoine Italiano, Iben Spanggaard, Makoto Ueno, Tomoya Yokota, Maria Luisa Veronese, Natalia Oliveira, Xin Li, Aidan Gilmartin, Michael Schaffer, Lipika Goyal
Pemigatinib in previously treated solid tumors with activating FGFR1-FGFR3 alterations: phase 2 FIGHT-207 basket trial. Nature medicine (2024)
Miho Kawashima, Takanori Kawabata, Chikako Ando, Megumi Sakuma, Takashi Aoyama, Hirofumi Ogawa, Tomoya Yokota, Yusuke Onozawa, Takashi Mukaigawa, Tetsuo Nishimura, Keita Mori, Takashi Yurikusa
Radiation-induced xerostomia and cariogenic dietary habits. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 32 (2) (2024)
Jordi Rodon Ahnert, Silvia Damian, Muhammad Furqan, Jesús García-Donas, Hiroo Imai, Antoine Italiano, Iben Spanggaard, Makoto Ueno, Tomoya Yokota, Maria Luisa Veronese, Natalia Oliveira, Xin Li, Aidan Gilmartin, Michael Schaffer, Lipika Goyal
Pemigatinib in previously treated solid tumors with activating FGFR1-FGFR3 alterations: phase 2 FIGHT-207 basket trial. Nature medicine 30 (6) (2024)
Miho Kawashima, Takanori Kawabata, Chikako Ando, Megumi Sakuma, Takashi Aoyama, Hirofumi Ogawa, Tomoya Yokota, Yusuke Onozawa, Takashi Mukaigawa, Tetsuo Nishimura, Keita Mori, Takashi Yurikusa
Radiation-induced xerostomia and cariogenic dietary habits. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 32 (2) (2024)
Miho Kawashima, Takanori Kawabata, Chikako Ando, Megumi Sakuma, Takashi Aoyama, Hirofumi Ogawa, Tomoya Yokota, Yusuke Onozawa, Takashi Mukaigawa, Tetsuo Nishimura, Keita Mori, Takashi Yurikusa
Radiation-induced xerostomia and cariogenic dietary habits. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 32 (2) (2024)
Miho Kawashima, Takanori Kawabata, Chikako Ando, Megumi Sakuma, Takashi Aoyama, Hirofumi Ogawa, Tomoya Yokota, Yusuke Onozawa, Takashi Mukaigawa, Tetsuo Nishimura, Keita Mori, Takashi Yurikusa
Radiation-induced xerostomia and cariogenic dietary habits. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 32 (2) (2024)
Jordi Rodon Ahnert, Silvia Damian, Muhammad Furqan, Jesús García-Donas, Hiroo Imai, Antoine Italiano, Iben Spanggaard, Makoto Ueno, Tomoya Yokota, Maria Luisa Veronese, Natalia Oliveira, Xin Li, Aidan Gilmartin, Michael Schaffer, Lipika Goyal
Publisher Correction: Pemigatinib in previously treated solid tumors with activating FGFR1-FGFR3 alterations: phase 2 FIGHT-207 basket trial. Nature medicine (2024)
Miho Kawashima, Takanori Kawabata, Chikako Ando, Megumi Sakuma, Takashi Aoyama, Hirofumi Ogawa, Tomoya Yokota, Yusuke Onozawa, Takashi Mukaigawa, Tetsuo Nishimura, Keita Mori, Takashi Yurikusa
Radiation-induced xerostomia and cariogenic dietary habits. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 32 (2) (2024)
Jordi Rodon Ahnert, Silvia Damian, Muhammad Furqan, Jesús García-Donas, Hiroo Imai, Antoine Italiano, Iben Spanggaard, Makoto Ueno, Tomoya Yokota, Maria Luisa Veronese, Natalia Oliveira, Xin Li, Aidan Gilmartin, Michael Schaffer, Lipika Goyal
Publisher Correction: Pemigatinib in previously treated solid tumors with activating FGFR1-FGFR3 alterations: phase 2 FIGHT-207 basket trial. Nature medicine (2024)
Jordi Rodon Ahnert, Silvia Damian, Muhammad Furqan, Jesús García-Donas, Hiroo Imai, Antoine Italiano, Iben Spanggaard, Makoto Ueno, Tomoya Yokota, Maria Luisa Veronese, Natalia Oliveira, Xin Li, Aidan Gilmartin, Michael Schaffer, Lipika Goyal
Publisher Correction: Pemigatinib in previously treated solid tumors with activating FGFR1-FGFR3 alterations: phase 2 FIGHT-207 basket trial. Nature medicine (2024)
Hiroya Taniguchi, Kentaro Yamazaki, Toshiki Masuishi, Takeshi Kawakami, Yusuke Onozawa, Kazunori Honda, Shigenori Kadowaki, Yukiya Narita, Takahiro Tsushima, Satoshi Hamauchi, Akiko Todaka, Tomoya Yokota, Masashi Ando, Keita Mori, Hiromichi Shirasu, Hirofumi Yasui, Kei Muro
Bevacizumab, Irinotecan, and Biweekly Trifluridine/Tipiracil for Metastatic Colorectal Cancer: MODURATE, a Phase Ib Study. The oncologist (2023)
Tomoya Yokota, Hiroki Yukino, Mihoko Doi, Hisatsugu Ohori
Real-world experience of tropomyosin receptor kinase inhibition with entrectinib in ETV6-NTRK3 positive metastatic salivary secretory carcinoma: A case series. Head & neck (2023)
Yuki Saito, Akihiro Homma, Naomi Kiyota, Makoto Tahara, Nobuhiro Hanai, Takahiro Asakage, Kazuto Matsuura, Ichiro Ota, Tomoya Yokota, Daisuke Sano, Takeshi Kodaira, Atsushi Motegi, Koichi Yasuda, Shunji Takahashi, Kaoru Tanaka, Takuma Onoe, Susumu Okano, Yoshinori Imamura, Yosuke Ariizumi, Ryuichi Hayashi
Human papillomavirus-related oropharyngeal carcinoma. Japanese journal of clinical oncology 52 (7) (2022)
Yoshinori Imamura, Naomi Kiyota, Makoto Tahara, Nobuhiro Hanai, Takahiro Asakage, Kazuto Matsuura, Ichiro Ota, Yuki Saito, Daisuke Sano, Takeshi Kodaira, Atsushi Motegi, Koichi Yasuda, Shunji Takahashi, Tomoya Yokota, Susumu Okano, Kaoru Tanaka, Takuma Onoe, Yosuke Ariizumi, Akihiro Homma
Systemic therapy for salivary gland malignancy: current status and future perspectives. Japanese journal of clinical oncology 52 (4) (2022)
Tomoya Yokota, Takao Ueno, Yoshihiko Soga, Hiroto Ishiki, Yasuhito Uezono, Takehiko Mori, Sadamoto Zenda, Yosuke Uchitomi
J-SUPPORT research policy for oral mucositis associated with cancer treatment. Cancer medicine (2022)
Ari Nishimura, Tomoya Yokota, Satoshi Hamauchi, Yusuke Onozawa, Hiromichi Shirasu, Takanori Kawabata, Hirofumi Ogawa, Tsuyoshi Onoe, Yoshiyuki Iida, Takashi Mukaigawa, Hirofumi Yasui
Incurable locoregional disease is a strong poor prognostic factor in recurrent or metastatic squamous cell carcinoma of the head and neck. International journal of clinical oncology 26 (10) (2021)
Tomoya Yokota, Tetsuro Onitsuka, Satoshi Hamauchi, Hiromichi Shirasu, Yusuke Onozawa, Yoshiyuki Iida, Tomoyuki Kamijo, Takashi Mukaigawa, Shinichi Okada, Yuki Irifune, Kotaro Ishida, Hirofumi Ogawa, Tsuyoshi Onoe
Triplet induction chemotherapy followed by less invasive surgery without reconstruction for human papillomavirus-associated oropharyngeal cancers: Why is it successful or unsuccessful? International journal of clinical oncology 26 (6) (2021)
Hiromichi Shirasu, Tomoya Yokota, Takeshi Kawakami, Satoshi Hamauchi, Yusuke Onozawa, Hirofumi Ogawa, Tsuyoshi Onoe, Keita Mori, Tetsuro Onitsuka
Efficacy and feasibility of induction chemotherapy with paclitaxel, carboplatin and cetuximab for locally advanced unresectable head and neck cancer patients ineligible for combination treatment with docetaxel, cisplatin, and 5-fluorouracil. International journal of clinical oncology 25 (11) (2020)
Hiromichi Shirasu, Tomoya Yokota, Satoshi Hamauchi, Yusuke Onozawa, Hirofumi Ogawa, Tsuyoshi Onoe, Tetsuro Onitsuka, Takashi Yurikusa, Keita Mori, Hirofumi Yasui
Risk factors for aspiration pneumonia during concurrent chemoradiotherapy or bio-radiotherapy for head and neck cancer. BMC cancer 20 (1) (2020)
Tomoya Yokota, Satoshi Hamauchi, Hiromichi Shirasu, Yusuke Onozawa, Hirofumi Ogawa, Tsuyoshi Onoe, Tetsuro Onitsuka
How Should We Approach Locally Advanced Squamous Cell Carcinoma of Head and Neck Cancer Patients Ineligible for Standard Non-surgical Treatment? Current oncology reports 22 (12) (2020)
Tomoya Yokota, Yosuke Ota, Hirofumi Fujii, Takeshi Kodaira, Mototsugu Shimokawa, Torahiko Nakashima, Nobuya Monden, Akihiro Homma, Shinya Ueda, Tetsuo Akimoto
Real-world clinical outcomes and prognostic factors in Japanese patients with recurrent or metastatic squamous cell carcinoma of head and neck treated with chemotherapy plus cetuximab: a prospective observation study (JROSG12-2). International journal of clinical oncology 26 (2) (2020)
Satoshi Hamauchi, Tomoya Yokota, Yusuke Onozawa, Hirofumi Ogawa, Tsuyoshi Onoe, Tomoyuki Kamijo, Yoshiyuki Iida, Tetsuro Onitsuka, Hirofumi Yasui
Chemoradiotherapy for high-risk stage II laryngeal cancer. International journal of clinical oncology 25 (9) (2020)
Hidenori Kimura, Satoshi Hamauchi, Sadayuki Kawai, Yusuke Onozawa, Hirofumi Yasui, Aiko Yamashita, Hirofumi Ogawa, Tsuyoshi Onoe, Tomoyuki Kamijo, Yoshiyuki Iida, Tetsuro Onitsuka, Tomoya Yokota
Pretreatment predictive factors for feasibility of oral intake in adjuvant concurrent chemoradiotherapy for patients with locally advanced squamous cell carcinoma of the head and neck. International journal of clinical oncology 25 (2) (2019)
Tomoya Yokota, Satoshi Hamauchi, Yukio Yoshida, Takashi Yurikusa, Miho Suzuki, Aiko Yamashita, Hirofumi Ogawa, Tsuyoshi Onoe, Keita Mori, Tetsuro Onitsuka
A phase II study of HMB/Arg/Gln against oral mucositis induced by chemoradiotherapy for patients with head and neck cancer. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 26 (9) (2018)
Tomoya Yokota, Takushi Yasuda, Hiroyuki Kato, Isao Nozaki, Hiroshi Sato, Yoshinori Miyata, Yoshifumi Kuroki, Ken Kato, Yasuo Hamamoto, Yasuhiro Tsubosa, Hirofumi Ogawa, Yoshinori Ito, Yuko Kitagawa
Concordance of clinical diagnosis of T classification among physicians for locally advanced unresectable thoracic esophageal cancer. International journal of clinical oncology 23 (1) (2017)
Tomoya Yokota, T Ogawa, S Takahashi, K Okami, T Fujii, K Tanaka, S Iwae, I Ota, T Ueda, N Monden, K Matsuura, H Kojima, S Ueda, K Sasaki, Y Fujimoto, Y Hasegawa, T Beppu, H Nishimori, S Hirano, Y Naka, Y Matsushima, M Fujii, M Tahara
Efficacy and safety of rebamipide liquid for chemoradiotherapy-induced oral mucositis in patients with head and neck cancer: a multicenter, randomized, double-blind, placebo-controlled, parallel-group phase II study. BMC cancer 17 (1) (2017)